对于疾病诊断和治疗的共价有机框架的合成和生物医学应用
Anyun Wang1, Xinli Liu2, Shujun Feng3
1School of Public Health, Wannan Medical College, Wuhu, 241002, China.
Chembiochem : a European journal of chemical biology
|November 13, 2024
概括
共价有机框架 (COF) 为生物医学用途提供了增强的稳定性和低细胞毒性. 本综述探讨了它们的合成,在疾病诊断和治疗中的应用,以及未来的潜力.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 聚合有机框架 (COF) 是一种由轻元素通过聚合键构成的多孔材料.
- 与金属有机框架 (MOF) 相比,COF表现出优越的稳定性和较低的细胞毒性,克服了体内应用的关键限制.
- 它们的高表面积,可调节的毛孔大小和可功能化的表面使它们成为各种生物医学应用的前景.
研究的目的:
- 为生物医学应用提供共价有机框架 (COF) 最近进展的全面概述.
- 概述适用于医疗用途的COF的合成方法.
- 讨论COFs的创新生物医学应用,挑战和未来前景.
主要方法:
- 对COFs的合成策略的审查.
- 探索COF在疾病诊断和治疗中的应用.
- 对挑战进行批判性讨论,包括临床翻译,生物相容性和药物输送.
主要成果:
- 由于其增强的稳定性和生物相容性,COF在生物医学领域为MOF提供了可行的替代品.
- 不同的合成路径使得能够创建适合特定医疗需求的COF.
- 在诊断成像,向药物输送和治疗干预方面,COF显示出潜力.
结论:
- 共价有机框架 (COFs) 对改变生物医学技术具有重大前景.
- 对临床转化,生物相容性和受控释放机制的进一步研究对于实现它们的全部潜力至关重要.
- COFs有望改善疾病诊断和治疗方法,为医学提供先进的解决方案.
更多相关视频
07:07Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
Published on: March 12, 2015
9.7K
08:42Microfluidic-based Synthesis of Covalent Organic Frameworks COFs: A Tool for Continuous Production of COF Fibers and Direct Printing on a Surface
Published on: July 10, 2017
13.3K
相关概念视频
Noncovalent Attractions in Biomolecules
Noncovalent attractions are associations within and between molecules that influence the shape and structural stability of complexes. These interactions differ from covalent bonding in that they do not involve sharing of electrons.
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Noncovalent Attractions in Biomolecules
Noncovalent attractions are associations within and between molecules that influence the shape and structural stability of complexes. These interactions differ from covalent bonding in that they do not involve sharing of electrons.
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
